한글목차

방사면역측정법(RIA) 동향 및 전망

세계 방사면역측정법(RIA: Radioimmunoassay) 시장은 2024년부터 2030년까지 연평균 3.2%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 암 발병률 증가, 의료 자동화에 대한 수요 증가, 의료 연구의 발전입니다. 세계 방사 면역 분석(RIA) 시장의 미래는 병원, 제약, 학술 및 임상 진단 실험실 시장에서 기회로 인해 유망한 것으로 보입니다.

방사면역측정법(RIA) 부문별 예측

이 조사에는 전 세계 방사면역측정법(RIA)의 유형별, 용도별, 최종 용도별, 지역별 예측이 포함되어 있습니다.

방사면역측정법(RIA) 시장 인사이트

Lucintel은 예측 기간 동안 시약 및 키트가 높은 성장세를 보일 것으로 예상하고 있습니다.

이 시장 중 임상검사실은 생물학적 시료 내 다양한 분석물을 고처리량, 고감도, 고특이성으로 분석할 수 있기 때문에 이 시설에서 방사면역측정법법을 많이 사용하기 때문에 가장 높은 성장이 예상됩니다.

북미지역은 유리한 상환정책과 탄탄한 의료시스템으로 인해 예측기간 동안 가장 규모가 큰 지역으로 남을 것으로 보입니다.

자주 묻는 질문

Q1. 시장 성장 예측은 다음과 같습니다.

A1. 세계 방사면역측정법(RIA) 시장은 2024년부터 2030년까지 연평균 복합 성장률(CAGR) 3.2%로 성장할 것으로 예상되는데, 그 이유는 무엇인가?

Q2. 시장 성장에 영향을 미치는 주요 촉진요인은 다음과 같습니다.

A2. 이 시장의 주요 촉진요인은 암 발병률 증가, 의료 자동화에 대한 수요 증가, 의료 연구의 발전입니다.

Q3. 시장의 주요 부문은 다음과 같습니다.

A3. 병원, 제약, 학계, 임상실험실 등 다양한 시장에서 기회가 많아 방사면역측정법(RIA) 시장의 미래는 매우 유망합니다.

Q4. 시장 주요 기업은 다음과 같습니다.

A4. 방사성 이온 분석(RIA) 주요 기업은 다음과 같습니다.

• DiaSource ImmunoAssays
• Beckman Coulter
• IBL International
• PerkinElmer
• DRG International
• MP Biomedicals
• Cisbio
• Euro Diagnostica
• DiaSorin
• EMD Millipore

Q5. 향후 가장 큰 시장 부문은 다음과 같습니다.

A5.Lucintel은 시약 및 키트는 예측 기간 동안 높은 성장세를 보일 것으로 예상하고 있습니다.

Q6. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은 어디입니까?

A6. 북미는 유리한 상환 정책을 이용할 수 있고, 탄탄한 의료 시스템이 존재하기 때문에 예측 기간 동안 가장 규모가 큰 지역으로 남을 것입니다.

Q7. 보고서 사용자 정의가 가능합니까?

A7. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 방사면역측정법(RIA) 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 방사면역측정법(RIA) 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 방사면역측정법(RIA) 시장(유형별)
  • 시약 및 키트
  • 분석 장비
• 세계의 방사면역측정법(RIA) 시장(용도별)
  • 임상 진단
  • 연구
• 최종 용도별 세계의 방사면역측정법(RIA) 시장
  • 병원
  • 제약
  • 학술
  • 임상 실험실
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018-2023년)

• 세계의 방사면역측정법(RIA) 시장 : 지역별
• 북미의 방사면역측정법(RIA) 시장
• 유럽의 방사면역측정법(RIA) 시장
• 아시아태평양의 방사면역측정법(RIA) 시장
• 기타 지역의 방사면역측정법(RIA) 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 방사면역측정법(RIA) 시장 성장 기회(유형별)
  • 용도별 세계의 방사면역측정법(RIA) 시장 성장 기회
  • 최종 용도별 세계의 방사면역측정법(RIA) 시장 성장 기회
  • 지역별 세계의 방사면역측정법(RIA) 시장 성장 기회
• 세계의 방사면역측정법(RIA) 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 방사면역측정법(RIA) 시장 능력 확대
  • 세계 방사면역측정법(RIA) 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증과 라이선싱

제7장 주요 기업 개요

• DiaSource ImmunoAssays
• Beckman Coulter
• IBL International
• PerkinElmer
• DRG International
• MP Biomedicals
• Cisbio
• Euro Diagnostica
• DiaSorin
• EMD Millipore

영문목차

Radioimmunoassay (RIA) Trends and Forecast

The future of the global radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets. The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030. The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Radioimmunoassay (RIA) by Segment

The study includes a forecast for the global radioimmunoassay (RIA) by type, application, end use, and region.

Radioimmunoassay (RIA) Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Reagents & Kits
• Analyzers

Radioimmunoassay (RIA) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Clinical Diagnostics
• Research

Radioimmunoassay (RIA) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Pharmaceuticals
• Academics
• Clinical Diagnostic Laboratories
• Others

Radioimmunoassay (RIA) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Radioimmunoassay (RIA) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radioimmunoassay (RIA) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radioimmunoassay (RIA) companies profiled in this report include-

• DiaSource ImmunoAssays
• Beckman Coulter
• IBL International
• PerkinElmer
• DRG International
• MP Biomedicals
• Cisbio
• Euro Diagnostica
• DiaSorin
• EMD Millipore

Radioimmunoassay (RIA) Market Insights

Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.

Within this market, clinical diagnostic laboratory is expected to witness the highest growth due to substantial usage of radioimmunoassay in this facility given to their ability to analyze a broad variety of analytes in biological samples with high throughput, high sensitivity, and specificity.

North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.

Features of the Global Radioimmunoassay (RIA) Market

Market Size Estimates: Radioimmunoassay (RIA) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Radioimmunoassay (RIA) market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Radioimmunoassay (RIA) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the radioimmunoassay (RIA) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radioimmunoassay (RIA) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for radioimmunoassay (RIA) market?

Answer: The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the radioimmunoassay (RIA) market?

Answer: The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.

Q3. What are the major segments for radioimmunoassay (RIA) market?

Answer: The future of the radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets.

Q4. Who are the key radioimmunoassay (RIA) market companies?

Answer: Some of the key radioimmunoassay (RIA) companies are as follows:

• DiaSource ImmunoAssays
• Beckman Coulter
• IBL International
• PerkinElmer
• DRG International
• MP Biomedicals
• Cisbio
• Euro Diagnostica
• DiaSorin
• EMD Millipore

Q5. Which radioimmunoassay (RIA) market segment will be the largest in future?

Answer: Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.

Q6. In radioimmunoassay (RIA) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the radioimmunoassay (RIA) market by type (reagents & kits and analyzers), application (clinical diagnostics and research), end use (hospitals, pharmaceuticals, academics, clinical diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Radioimmunoassay (RIA) Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Radioimmunoassay (RIA) Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Radioimmunoassay (RIA) Market by Type
  • 3.3.1: Reagents & Kits
  • 3.3.2: Analyzers
• 3.4: Global Radioimmunoassay (RIA) Market by Application
  • 3.4.1: Clinical Diagnostics
  • 3.4.2: Research
• 3.5: Global Radioimmunoassay (RIA) Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Pharmaceuticals
  • 3.5.3: Academics
  • 3.5.4: Clinical Diagnostic Laboratories
  • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Radioimmunoassay (RIA) Market by Region
• 4.2: North American Radioimmunoassay (RIA) Market
  • 4.2.1: North American Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
  • 4.2.2: North American Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
• 4.3: European Radioimmunoassay (RIA) Market
  • 4.3.1: European Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
  • 4.3.2: European Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
• 4.4: APAC Radioimmunoassay (RIA) Market
  • 4.4.1: APAC Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
  • 4.4.2: APAC Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
• 4.5: ROW Radioimmunoassay (RIA) Market
  • 4.5.1: ROW Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
  • 4.5.2: ROW Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Type
  • 6.1.2: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Application
  • 6.1.3: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by End Use
  • 6.1.4: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Region
• 6.2: Emerging Trends in the Global Radioimmunoassay (RIA) Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Radioimmunoassay (RIA) Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radioimmunoassay (RIA) Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: DiaSource ImmunoAssays
• 7.2: Beckman Coulter
• 7.3: IBL International
• 7.4: PerkinElmer
• 7.5: DRG International
• 7.6: MP Biomedicals
• 7.7: Cisbio
• 7.8: Euro Diagnostica
• 7.9: DiaSorin
• 7.10: EMD Millipore